Maurice Beghetti

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


66 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
2024
 
Atrial Septal Defect, Pulmonary Arterial Hypertension, and Diastolic Left Heart Failure: When 3 Players Come into the Game.
Rutz T., Aubert J.D., Beghetti M., Eeckhout E., Muller O., Bouchardy J., Yerly P., 2024/05. Circulation. Heart failure, 17 (5) pp. e010545. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA9E3181564C]
2023
Pediatric Population Pharmacokinetic Modeling and Exposure-Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data.
Okour M., Thapar M.M., Farrell C., Lukas M.A., Beghetti M., Beerahee M., 2023/05. Journal of clinical pharmacology, 63 (5) pp. 593-603. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CBE3CF25965C]
Three-dimensional printing and virtual reconstruction in surgical planning of double-outlet right ventricle repair.
Ponchant K., Nguyen D.A., Prsa M., Beghetti M., Sologashvili T., Vallée J.P., 2023/02. JTCVS techniques, 17 pp. 138-150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C50B04C3A290]
2022
Correlation between Pulmonary Artery Pressure and Vortex Duration Determined by 4D Flow MRI in Main Pulmonary Artery in Patients with Suspicion of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Deux J.F., Crowe L.A., Genecand L., Hachulla A.L., Glessgen C.G., Noble S., Beghetti M., Ning J., Giese D., Lador F. et al., 2022/09/05. Journal of clinical medicine, 11 (17) p. 5237. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB633C3F8F18]
Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD study.
García Aguilar H., Gorenflo M., Ivy D.D., Moledina S., Castaldi B., Ishida H., Cześniewicz P., Kusa J., Miera O., Pattathu J. et al., 2022/07. Pulmonary circulation, 12 (3) pp. e12133. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1B8D3ADE9F89]
Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension.
Crowe L.A., Genecand L., Hachulla A.L., Noble S., Beghetti M., Vallée J.P., Lador F., 2022/05/11. Journal of clinical medicine, 11 (10) p. 2717. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_376DC3653C7D]
Contribution of imaging modalities to eosinophilic myocarditis diagnosis: a case report.
Farhat N., Bouhabib M., Joye R., Vallée J.P., Beghetti M., 2022/02. European heart journal. Case reports, 6 (2) pp. ytac058. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1DEF6F91070F]
2021
Nitric Oxide-cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension.
Reinero M., Beghetti M., Tozzi P., Segesser LKV, Samaja M., Milano G., 2021/11. Journal of cardiovascular pharmacology and therapeutics, 26 (6) pp. 665-676. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F1AC8791D65]
 
Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
Grady R.M., Canter M.W., Wan F., Shmalts A.A., Coleman R.D., Beghetti M., Berger RMF, Del Cerro Marin M.J., Fletcher S.E., Hirsch R. et al., 2021/08/03. Journal of the American College of Cardiology, 78 (5) pp. 468-477. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B8AEF1C7CA74]
 
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysis.
Apitz C., Berger RMF, Ivy D.D., Humpl T., Bonnet D., Beghetti M., Schranz D., Latus H., 2021/08. Cardiovascular diagnosis and therapy, 11 (4) pp. 1037-1047. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5515AC7B9337]
 
Selexipag for the treatment of pulmonary arterial hypertension.
Genecand L., Wacker J., Beghetti M., Lador F., 2021/05. Expert review of respiratory medicine, 15 (5) pp. 583-595. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A1BB2A3A6225]
 
Double-root inversion for complex malposition of the great arteries with tricuspid valve straddling.
Nalecz T., De Ferm A., Pelouze A., Beghetti M., Prêtre R., Sologashvili T., 2021/03/08. Multimedia manual of cardiothoracic surgery, 2021. Peer-reviewed.
[DOI][Pmid][serval:BIB_525F0283E80B]
 
Outcome of paediatric portopulmonary hypertension in the modern management era: A case report of 6 patients.
Joye R., Lador F., Aggoun Y., Farhat N., Wacker J., Wildhaber B.E., Vallée J.P., Hachulla A.L., McLin V.A., Beghetti M., 2021/03. Journal of hepatology, 74 (3) pp. 742-747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9BA87B648117]
 
Cardiac Output Determination in Precapillary Pulmonary Hypertension: A Systematic Review.
Genecand L., Adler D., Beghetti M., Lador F., 2021. Respiration; international review of thoracic diseases, 100 (12) pp. 1243-1250. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D73F7BC9970E]
Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study.
Beghetti M., Berger RMF, Bonnet D., Grill S., Lesage C., Lemarie J.C., Ivy D.D., 2021. Frontiers in pediatrics, 9 p. 681538. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D05FC270DB08]
2020
 
"Micro-Bentall" procedure.
Pelouze A., Prêtre R., Beghetti M., Sologashvili T., 2020/12/24. Multimedia manual of cardiothoracic surgery, 2020. Peer-reviewed.
[DOI][Pmid][serval:BIB_17A1DEA713CE]
 
A 13-Year-Old Male With Diagnosed Idiopathic Pulmonary Hypertension: Is it Really Idiopathic?
Wacker J., Aggoun Y., Terraz S., Golay E., Maggio ABR, Vallée J.P., Hachulla A.L., Lador F., Barazzone C., McLin V. et al., 2020/12. Chest, 158 (6) pp. e295-e298. Peer-reviewed.
[DOI][Pmid][serval:BIB_EDC123E1CA8C]
 
SCN8A heterozygous variants are associated with anoxic-epileptic seizures.
Ranza E., Z'Graggen W., Lidgren M., Beghetti M., Guipponi M., Antonarakis S.E., Absoud M., Goyal S., Pal D.K., Korff C.M., 2020/05. American journal of medical genetics. Part A, 182 (5) pp. 1209-1216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8FCD6C87777B]
2019
 
Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension.
Sallmon H., Moledina S., Albert D.C., Beghetti M., Berger RMF, Bonnet D., Bukova M., Koestenberger M., Meinel K., Reinhardt Z. et al., 2019/11. Cardiology in the young, 29 (11) pp. 1323-1327. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6EBE437339DF]
 
Impact of Liver Diseases on Heart and Lungs.
Hachulla A.L., Rautou P.E., Franchi-Abella S., Lagadec M., Mueller H., Noble S., Bouchardy J., Lambert V., Lador F., Beghetti M. et al., 2019/10. JACC. Cardiovascular imaging, 12 (10) pp. 2071-2075. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_16664FCD9FC0]
 
Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry.
Beghetti M., Brand M., Berger RMF, Humpl T., Wheeler J.G., Ivy D.D., Bonnet D., TOPP investigators, 2019/08/15. International journal of cardiology, 289 pp. 110-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D00607894D1]
Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia.
Nydegger C., Corno A.F., von Segesser L.K., Beghetti M., Samaja M., Milano G., 2019/08. Cardiovascular drugs and therapy, 33 (4) pp. 407-414. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_37732824A371]
Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail.
Berger RMF, Beghetti M., 2019/06/01. American journal of respiratory and critical care medicine, 199 (11) pp. 1306-1307. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5B0F3D7F5A32]
 
Congenital Portosystemic Shunts: Current Diagnosis and Management.
McLin V.A., Franchi Abella S., Debray D., Guérin F., Beghetti M., Savale L., Wildhaber B.E., Gonzales E., Members of the International Registry of Congenital Porto-Systemic Shunts, 2019/05. Journal of pediatric gastroenterology and nutrition, 68 (5) pp. 615-622. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3783FD614ED]
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
Beghetti M., Channick R.N., Chin K.M., Di Scala L., Gaine S., Ghofrani H.A., Hoeper M.M., Lang I.M., McLaughlin V.V., Preiss R. et al., 2019/03. European journal of heart failure, 21 (3) pp. 352-359. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E88556185F8F]
 
An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence.
Wacker J., Weintraub R., Beghetti M., 2019/02. Expert review of respiratory medicine, 13 (2) pp. 205-215. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7973BAF1AECB]
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Gatzoulis M.A., Landzberg M., Beghetti M., Berger R.M., Efficace M., Gesang S., He J., Papadakis K., Pulido T., Galiè N. et al., 2019/01/02. Circulation, 139 (1) pp. 51-63. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2B3253EE0026]
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.
Rosenzweig E.B., Abman S.H., Adatia I., Beghetti M., Bonnet D., Haworth S., Ivy D.D., Berger RMF, 2019/01. The European respiratory journal, 53 (1) p. 1801916. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7F24E41BA134]
Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls.
Farhat N., Cools B., Gewillig M., Seghaye M.C., Aggoun Y., Beghetti M., 2019. Frontiers in pediatrics, 7 p. 262. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0BEDB75E1816]
2018
 
Regression of Advanced Liver Fibrosis After Heart Transplantation in a Patient With Prior Fontan Surgery for Complex Congenital Heart Disease.
Bouchardy J., Meyer P., Yerly P., Blanche C., Hullin R., Giostra E., Hanquinet S., Rubbia-Brandt L., Sekarski N., Prêtre R. et al., 2018/11. Circulation. Heart failure, 11 (11) pp. e003754. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_10CDB3F3FBC5]
 
Two-stage arterial switch for late-presenting transposition of the great arteries.
Sologashvili T., Wannaz L., Beghetti M., Aggoun Y., Prêtre R., Myers P.O., 2018/10/01. Interactive cardiovascular and thoracic surgery, 27 (4) pp. 581-585. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2D08090D0042]
 
Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Blanche C., Alonso-Gonzalez R., Uribarri A., Kempny A., Swan L., Price L., Wort S.J., Beghetti M., Dimopoulos K., 2018/09/15. International journal of cardiology, 267 pp. 79-83. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D28412E81700]
 
Rotation of the outflow tracts.
Sologashvili T., Myers P.O., Beghetti M., Prêtre R., 2018/09/01. Interactive cardiovascular and thoracic surgery, 27 (3) pp. 463-464. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B71999B05699]
 
Serum cardiovascular risk biomarkers in pre-pubertal obese children.
Maggio ABR, Farpour-Lambert N.J., Aggoun Y., Galan K., Montecucco F., Mach F., Beghetti M., 2018/09. European journal of clinical investigation, 48 (9) pp. e12995. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8C3D1489424]
Definition and Management of Segmental Pulmonary Hypertension.
Dimopoulos K., Diller G.P., Opotowsky A.R., D'Alto M., Gu H., Giannakoulas G., Budts W., Broberg C.S., Veldtman G., Swan L. et al., 2018/07/04. Journal of the American Heart Association, 7 (14). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_763030A17680]
 
Rotation of the outflow tracts for complex transposition of the great arteries.
Myers P.O., Sologashvili T., Beghetti M., Prêtre R., 2018/07/03. Multimedia manual of cardiothoracic surgery, 2018. Peer-reviewed.
[DOI][Pmid][serval:BIB_EF29B6DA4BB7]
 
Modern Invasive Hemodynamic Assessment of Pulmonary Hypertension.
Pagnamenta A., Lador F., Azzola A., Beghetti M., 2018. Respiration; international review of thoracic diseases, 95 (3) pp. 201-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D4C271BE0163]
2017
 
Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.
Zhang H.D., Lv Z.C., Wang L.T., Rothman A., Lian T.Y., He Y.Y., Wu Y., Lawrie A., Beghetti M., Jing Z.C., 2017/12/01. American journal of respiratory and critical care medicine, 196 (11) pp. 1478-1481. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D2461108E65]
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3.
Berger RMF, Gehin M., Beghetti M., Ivy D., Kusic-Pajic A., Cornelisse P., Grill S., Bonnet D., FUTURE-3 investigators, 2017/08. British journal of clinical pharmacology, 83 (8) pp. 1734-1744. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91482515D4DF]
 
Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
Humpl T., Berger RMF, Austin E.D., Fasnacht Boillat M.S., Bonnet D., Ivy D.D., Zuk M., Beghetti M., Schulze-Neick I., 2017/08. Cardiology in the young, 27 (6) pp. 1123-1132. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFB00EE527D2]
Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
Beghetti M., Rudzinski A., Zhang M., 2017/07/04. BMC cardiovascular disorders, 17 (1) p. 177. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A5F1C22FB19B]
Adapting the "Chester step test" to predict peak oxygen uptake in children.
Maggio ABR, Vuistiner P., Crettenand A., Tabin R., Martin X.E., Beghetti M., Farpour-Lambert N.J., Deriaz O., 2017/06/21. Swiss medical weekly, 147 pp. w14435. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B678AE97BC4]
 
Pediatric Development of Bosentan Facilitated by Modeling and Simulation.
Zisowsky J., Géhin M., Kusic-Pajic A., Krause A., Beghetti M., Dingemanse J., 2017/04. Paediatric drugs, 19 (2) pp. 121-130. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9CB3789C79B5]
 
<i>Pectus excavatum</i> et <i>carinatum</i> chez l’enfant et l’adolescent : que dire, que faire ? [Pectus excavatumn and carinatum in children and adolescents : what to say, what to do ?]
Lascombes P., Ruchonnet-Métrailler I., Beghetti M., Bottani A., Wilde J., 2017/02/15. Revue medicale suisse, 13 (550) pp. 414-420. Peer-reviewed.
[Pmid][serval:BIB_7A9ED7EFB981]
Echocardiographic Evaluation of Pulmonary Pressures and Right Ventricular Function after Pediatric Cardiac Surgery: A Simple Approach for the Intensivist.
Beghetti M., 2017. Frontiers in pediatrics, 5 p. 184. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14F5E0335547]
 
Invasive haemodynamic evaluation of the pulmonary circulation in pulmonary hypertension.
Pagnamenta A., Azzola A., Beghetti M., Lador F., 2017. Swiss medical weekly, 147 pp. w14445. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58095F2A6702]
2016
 
Yasui procedure.
Myers P., Sologashvili T., Wacker J., Vallée J.P., Beghetti M., Prêtre R., 2016/12/09. Multimedia manual of cardiothoracic surgery : MMCTS, 2016 p. 0. Peer-reviewed.
[DOI][Pmid][serval:BIB_3CA61933AB18]
 
Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].
Berger R.M., Haworth S.G., Bonnet D., Dulac Y., Fraisse A., Galiè N., Ivy D.D., Jaïs X., Miera O., Rosenzweig E.B. et al., 2016/11/15. International journal of cardiology, 223 pp. 1072-1073. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14593D93B3BA]
 
Response by Myers and Beghetti to Letter Regarding Article, "Unrestrictive Aortopulmonary Window: Extreme Presentation as Non-Eisenmenger in a 30-Year-Old Patient".
Myers P.O., Beghetti M., 2016/10/11. Circulation, 134 (15) pp. e330-e331. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9965017C7456]
 
Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial.
Steinhorn R.H., Fineman J., Kusic-Pajic A., Cornelisse P., Gehin M., Nowbakht P., Pierce C.M., Beghetti M., FUTURE-4 study investigators, 2016/10. The Journal of pediatrics, 177 pp. 90-96.e3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6F62198A0D0]
 
Surgical Repair of Mitral Valve Disease in Children: Perioperative Changes in Respiratory Function.
Malaspinas I., Petak F., Chok L., Perrin A., Martin A.L., Beghetti M., Habre W., 2016/10. Journal of cardiothoracic and vascular anesthesia, 30 (5) pp. 1286-1295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08B0BF03029C]
Successful Lung Transplant After Prolonged Extracorporeal Membrane Oxygenation (ECMO) in a Child With Pulmonary Hypertension: A Case Report.
Tissot C., Habre W., Soccal P., Hug M.I., Bettex D., Pellegrini M., Aggoun Y., Mornand A., Kalangos A., Rimensberger P. et al., 2016/08. Research in cardiovascular medicine, 5 (3) pp. e32545. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2B9AD9DB93ED]
 
Norwood Stage 1 With Surgical Ventricular Reconstruction and Mitral Valve Repair for Neonatal Idiopathic Left Ventricular Dilated Cardiomyopathy.
Myers P.O., Sologashvili T., Beghetti M., Tissot C., 2016/07. The Annals of thoracic surgery, 102 (1) pp. e15-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6AB7524FA23E]
 
eComment: How to define operability in pulmonary hypertension secondary to congenital heart disease?
Myers P.O., Lador F., Beghetti M., 2016/06. Interactive cardiovascular and thoracic surgery, 22 (6) p. 859. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0C4075A75176]
 
BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease.
Liu D., Liu Q.Q., Guan L.H., Jiang X., Zhou D.X., Beghetti M., Qu J.M., Jing Z.C., 2016/05/15. International journal of cardiology, 211 pp. 132-136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D47C62FE944]
 
Unrestrictive Aortopulmonary Window: Extreme Presentation as Non-Eisenmenger in a 30-Year-Old Patient.
Myers P.O., Lador F., Hachulla A.L., Bouchardy J., Noble S., Licker M., Pache J.C., Kalimanovaska-Ostric D., Djukic M., Kalangos A. et al., 2016/05/10. Circulation, 133 (19) pp. 1907-1910. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F656FB9890AD]
 
Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study.
Ploegstra M.J., Ivy D.D., Wheeler J.G., Brand M., Beghetti M., Rosenzweig E.B., Humpl T., Iriart X., Rouzic E.M., Bonnet D. et al., 2016/04. The Lancet. Respiratory medicine, 4 (4) pp. 281-290. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41BF712D26F4]
 
Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
Douwes J.M., Humpl T., Bonnet D., Beghetti M., Ivy D.D., Berger R.M., TOPP Investigators, 2016/03/22. Journal of the American College of Cardiology, 67 (11) pp. 1312-1323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_205C88702A1E]
Pulmonary hypertension in the elderly: a different disease?
Berra G., Noble S., Soccal P.M., Beghetti M., Lador F., 2016/03. Breathe, 12 (1) pp. 43-49. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2755268A6718]
 
To "Cath" or Not in Pediatric Pulmonary Hypertension?
Beghetti M., Berger R.M., Ivy D.D., Bonnet D., Humpl T., 2016/03/01. Journal of the American College of Cardiology, 67 (8) pp. 1010-1011. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3EE2ABC2169B]
 
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.
Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., Simonneau G., Peacock A., Vonk Noordegraaf A., Beghetti M. et al., 2016/02. Revista espanola de cardiologia, 69 (2) p. 177. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0C0C84AF4E5C]
 
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).
Beghetti M., Schulze-Neick I., Berger R.M., Ivy D.D., Bonnet D., Weintraub R.G., Saji T., Yung D., Mallory G.B., Geiger R. et al., 2016/01/15. International journal of cardiology, 203 pp. 325-330. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_056B93134C5D]
 
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., Simonneau G., Peacock A., Vonk Noordegraaf A., Beghetti M. et al., 2016/01/01. European heart journal, 37 (1) pp. 67-119. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B4F4E8FB9BD5]
 
Dual-energy computed tomographic imaging of pulmonary hypertension.
Hachulla A.L., Lador F., Soccal P.M., Montet X., Beghetti M., 2016. Swiss medical weekly, 146 pp. w14328. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A73B7A3E89A]
 
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.
Berger R.M., Haworth S.G., Bonnet D., Dulac Y., Fraisse A., Galiè N., Ivy D.D., Jaïs X., Miera O., Rosenzweig E.B. et al., 2016/01/01. International journal of cardiology, 202 pp. 52-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B9D40399038E]
Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension.
Lador F., Bringard A., Bengueddache S., Ferretti G., Bendjelid K., Soccal P.M., Noble S., Beghetti M., Chemla D., Hervé P. et al., 2016. BioMed research international, 2016 p. 6050193. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D408F465ABEA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University